Eton Pharmaceutical
ETON
54.88
+0.11
+0.20%
Eton Pharmaceutical
US · ETON
#2944 by market cap
Listed 2018
54.88
+0.11
+0.20%
Live - 5344 symbols - heartbeat 415s ago
· 2026-10-08 05:11
Pre-market
54.96
+0.15%
After-hours
55.10
+0.40%
- Market cap
- 1.57B
- P/E (TTM)i
- 140.72
- P/Bi
- 33.67
- EPSi
- -0.17
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on ETON?
Anonymous reader poll. Unscientific, not investment advice.
About Eton Pharmaceutical
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
- Founded
- 2017
- Employees
- 44
- Headquarters
- Deer Park, Illinois, United States of America
- Fiscal year end
- 12-31
- Website
- etonpharma.com
Company profile
- Exchange
- US
- Symbol
- ETON
- Market-cap rank
- #2944
- Listing date
- 2018-11-09
- Market cap
- 1.57B
- Float cap
- 1.22B
- Shares out
- 28.58M
- Float shares
- 22.30M
Sectors & themes
Quote time 2026-10-08 05:11:58 · For reference only, not investment advice and not tailored to your situation.